Renata Duchnowska

2.0k total citations
68 papers, 1.1k citations indexed

About

Renata Duchnowska is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Renata Duchnowska has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Renata Duchnowska's work include Brain Metastases and Treatment (25 papers), HER2/EGFR in Cancer Research (20 papers) and Lung Cancer Treatments and Mutations (17 papers). Renata Duchnowska is often cited by papers focused on Brain Metastases and Treatment (25 papers), HER2/EGFR in Cancer Research (20 papers) and Lung Cancer Treatments and Mutations (17 papers). Renata Duchnowska collaborates with scholars based in Poland, United States and United Kingdom. Renata Duchnowska's co-authors include Jacek Jassem, Cezary Szczylik, Wojciech Biernat, Barbara Radecka, Bogumiła Czartoryska-Arłukowicz, Sibylle Loibl, Bartłomiej Grala, Karolina Skonieczna‐Żydecka, Ted R. Hupp and Karol Połom and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Renata Duchnowska

60 papers receiving 1.1k citations

Peers

Renata Duchnowska
Bo H. Chao United States
Christopher Ruel United States
Adam Cooper Australia
Wen Liu China
Steven McCune United States
Bo H. Chao United States
Renata Duchnowska
Citations per year, relative to Renata Duchnowska Renata Duchnowska (= 1×) peers Bo H. Chao

Countries citing papers authored by Renata Duchnowska

Since Specialization
Citations

This map shows the geographic impact of Renata Duchnowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Duchnowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Duchnowska more than expected).

Fields of papers citing papers by Renata Duchnowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Duchnowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Duchnowska. The network helps show where Renata Duchnowska may publish in the future.

Co-authorship network of co-authors of Renata Duchnowska

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Duchnowska. A scholar is included among the top collaborators of Renata Duchnowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Duchnowska. Renata Duchnowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khan, Imran, Brunilde Gril, Anurag N. Paranjape, et al.. (2023). Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer. Molecular Cancer Therapeutics. 22(5). 646–658. 3 indexed citations
3.
Kaźmierczak-Siedlecka, Karolina, Karolina Skonieczna‐Żydecka, Ted R. Hupp, et al.. (2022). Next-generation probiotics – do they open new therapeutic strategies for cancer patients?. Gut Microbes. 14(1). 2035659–2035659. 86 indexed citations
4.
Niwińska, Anna, Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, & Renata Duchnowska. (2022). Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy. Cancers. 14(4). 965–965. 6 indexed citations
5.
Pęksa, Rafał, et al.. (2020). Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer. Scientific Reports. 10(1). 1871–1871. 6 indexed citations
6.
Nicoś, Marcin, Silvano Garnerone, Anna Kowalczyk, et al.. (2019). P2.01-66 Genomic Landscapes of DNA Copy Number Alterations in Primary Lung Cancers and Matched Brain Metastases. Journal of Thoracic Oncology. 14(10). S665–S666. 1 indexed citations
7.
Duchnowska, Renata, Sibylle Loibl, & Jacek Jassem. (2018). Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer. Cancer Treatment Reviews. 67. 71–77. 63 indexed citations
8.
Duchnowska, Renata. (2017). Pseudoprogression during immunotherapy of cancers. Oncology in Clinical Practice. 13(2). 57–60. 2 indexed citations
9.
Lyle, L. Tiffany, Paul R. Lockman, Chris E. Adkins, et al.. (2016). Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clinical Cancer Research. 22(21). 5287–5299. 120 indexed citations
10.
Duchnowska, Renata, Ewa Chmielowska, Joanna Streb, et al.. (2016). The role of anthracyclines and dose dense therapy in an adjuvant setting, in HER2-positive early breast cancer, in clinical practice. Oncology in Clinical Practice. 12(1). 8–11. 1 indexed citations
12.
Duchnowska, Renata, Jacek Jassem, Chirayu Goswami, et al.. (2015). Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients. Journal of Neuro-Oncology. 122(1). 205–216. 29 indexed citations
13.
Palmieri, Diane, Renata Duchnowska, Stephan Woditschka, et al.. (2014). Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner. Clinical Cancer Research. 20(10). 2727–2739. 45 indexed citations
14.
Jassem, Jacek, Renata Duchnowska, Andrzej Kawecki, et al.. (2014). Post-treatment surveillance in most common solid malignancies in adults. Oncology in Clinical Practice. 10(6). 290–313. 1 indexed citations
15.
Khan, Mohammed Imran, Anna M. Czarnecka, Renata Duchnowska, Wojciech Kukwa, & Cezary Szczylik. (2014). Metastasis-Initiating Cells in Renal Cancer. Current Signal Transduction Therapy. 8(3). 240–246. 17 indexed citations
16.
Minuti, Gabriele, Federico Cappuzzo, Renata Duchnowska, et al.. (2012). Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer. British Journal of Cancer. 107(5). 793–799. 93 indexed citations
17.
Duchnowska, Renata, Rafał Dziadziuszko, Tomasz Trojanowski, et al.. (2012). Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Research. 14(4). R119–R119. 77 indexed citations
18.
Preusser, Matthias, Frank Winkler, Laurence Collette, et al.. (2012). Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. European Journal of Cancer. 48(18). 3439–3447. 37 indexed citations
19.
Bodnar, Lubomir, et al.. (2011). The role of Tau protein in resistance to paclitaxel. Cancer Chemotherapy and Pharmacology. 68(3). 553–557. 64 indexed citations
20.
Duchnowska, Renata, Rafał Dziadziuszko, Bogumiła Czartoryska-Arłukowicz, et al.. (2009). Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. Breast Cancer Research and Treatment. 117(2). 297–303. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026